摘要
目的研究祛痰化瘀法联合噻托溴铵雾化吸入治疗对慢性阻塞性肺疾病(COPD)缓解期患者康复进程及肺功能的影响。方法选取我院2012年3月-2014年9月COPD缓解期患者84例作为研究对象,将患者随机分为观察组和对照组,每组42例,观察组采用祛痰化瘀法联合噻托溴铵雾化吸入治疗,对照组采用单纯噻托溴铵雾化吸入治疗,比较两组肺功能改善情况。结果观察组治疗后的1 s用力呼气容积(FEV1)为(2.34±0.59)L,高于对照组的(1.82±0.63)L(P〈0.05)。结论祛痰化瘀法联合噻托溴铵雾化吸入治疗COPD缓解期患者,具有宣肃肺气、化痰理气、泻热祛淤的功效,可以缓解患者的临床症状,改善肺功能,同时提高患者的免疫力,加快康复进程。
Objective To study effects of expelling phlegm and relieving blood stasis principle combined with tiotropium bromide aerosol inhalation treatment on recovery process and lung function of patients with chronic obstructive pulmoriary disease(COPD) in remission. Methods 84 COPD patients in remission of our hospital from March 2012 to September 2014 were selected as the research objects, they were randomly divided intoobservation group and control group, 42 cases in each group, observation group was given expelling phlegm and relieving blood stasis principle combined with tiotropium bromide aerosol inhalation treatment, control group was given simple tiotropium bromide aerosol inhalation treatment, clinical efficacy and improvement of lung function of two groups were compared. Results The 1s forced expiratory volume(FEV1) in the observation group was(2.34±0.59) L, higher than that in the control group(1.82±0.63) L(P〈0.05).Conclusion Expelling phlegm and relieving blood stasis principle combined with tiotropium bromide aerosol inhalation treatment for COPD patients in remission has the effects of xuansufeiqi, resolving phlegm, regulating qi, purging heat and removing silt, can relieve clinical symptoms and improve lung function, and improve patients' immunity, speed up recovery process.
出处
《中国继续医学教育》
2016年第23期192-193,共2页
China Continuing Medical Education
关键词
慢性阻塞性肺疾病
缓解期
祛痰化瘀法
噻托溴铵
Chronic obstructive pulmoriary disease
Remission
Expelling phlegm and relieving blood stasis principle
Tiotropium bromide